Skip to content

Home Search Authors Pakistan News Saved

SciRah

SciRah does not host or store research papers. Results come live from free, official scholarly APIs, and every paper links back to its original source.

Data sources

OpenAlex
Semantic Scholar
Crossref
CORE
arXiv
PubMed

Privacy policy Terms of service

F. Dippel · SciRah

Researcher profile · Semantic Scholar

F. Dippel

Share profile

F. Dippel — researcher profile on SciRah

h-index: 12
Works: 42
Citations: 1,144

Most-cited papers

Systematic literature review and validity evaluation of the Expanded Disability Status Scale (EDSS) and the Multiple Sclerosis Functional Composite (MSFC) in patients with multiple sclerosis
S. Meyer-Moock, You-Shan Feng, M. Maeurer, F. Dippel +1 more
2013BMC Neurology625 citations Open access
Semantic Scholar
Amputation rate and risk factors in type 2 patients with diabetic foot syndrome under real-life conditions in Germany.
S. Pscherer, F. Dippel, S. Lauterbach, K. Kostev
2012Primary Care Diabetes103 citations
Semantic Scholar
Utilization of lipid-modifying therapy and low-density lipoprotein cholesterol goal attainment in patients at high and very-high cardiovascular risk: Real-world evidence from Germany.
W. März, F. Dippel, K. Theobald, K. Gorcyca +2 more
2018Atherosclerosis87 citations Open access
Semantic Scholar
Fracture risk in patients with type 2 diabetes under different antidiabetic treatment regimens: a retrospective database analysis in primary care
K. Kostev, S. Pscherer, W. Rathmann, F. Dippel
2016Diabetes, Metabolic Syndrome and Obesity : Targets and Therapy33 citations Open access
Semantic Scholar
Predictors of hypoglycaemia in insulin-treated type 2 diabetes patients in primary care: a retrospective database analysis.
K. Kostev, F. Dippel, W. Rathmann
2014Primary Care Diabetes33 citations
Semantic Scholar
Relevance of indirect comparisons in the German early benefit assessment and in comparison to HTA processes in England, France and Scotland
A. Lebioda, D. Gasche, F. Dippel, K. Theobald +1 more
2014Health Economics Review26 citations Open access
Semantic Scholar
Glycemic control after initiating basal insulin therapy in patients with type 2 diabetes: a primary care database analysis
K. Kostev, F. Dippel, W. Rathmann
2015Diabetes, Metabolic Syndrome and Obesity : Targets and Therapy22 citations Open access
Semantic Scholar
Health economic evaluation of insulin glargine vs NPH insulin in intensified conventional therapy for type 1 diabetes in Germany
M. Pfohl, P. Schädlich, F. Dippel, Katharina C. Koltermann
2012Journal of Medical Economics21 citations
Semantic Scholar
Resource utilisation and costs in patients with type 2 diabetes mellitus treated with insulin glargine or conventional basal insulin under real-world conditions in Germany: LIVE-SPP study
O. Schöffski, L. Breitscheidel, U. Benter, F. Dippel +3 more
2008Journal of Medical Economics21 citations Open access
Semantic Scholar
Treatment persistence after initiating basal insulin in type 2 diabetes patients: A primary care database analysis.
S. Pscherer, E. Chou, F. Dippel, W. Rathmann +1 more
2015Primary Care Diabetes19 citations
Semantic Scholar
Statin‐associated myopathy. Assessment of frequency based on data of all statutory health insurance funds in Germany
P. Ihle, F. Dippel, I. Schubert
2018Pharmacology Research & Perspectives13 citations Open access
Semantic Scholar
Early Discontinuation and Related Treatment Costs After Initiation of Basal Insulin in Type 2 Diabetes Patients
H. Anderten, F. Dippel, K. Kostev
2015Journal of Diabetes Science and Technology13 citations Open access
Semantic Scholar
Treatment duration (persistence) of basal insulin supported oral therapy (BOT) in Type-2 diabetic patients: comparison of insulin glargine with NPH insulin.
R. Quinzler, Miriam Ude, A. Franzmann, Sandra Feldt +5 more
2012International journal of clinical pharmacology and therapeutics12 citations
Semantic Scholar
Health economic evaluations comparing insulin glargine with NPH insulin in patients with type 1 diabetes: a systematic review
Ernst-Günther Hagenmeyer, Katharina C. Koltermann, F. Dippel, P. Schädlich
2011Cost Effectiveness and Resource Allocation11 citations Open access
Semantic Scholar
Treatment Preferences in Germany Differ Among Apheresis Patients with Severe Hypercholesterolemia
A. Mühlbacher, A. Sadler, F. Dippel, C. Juhnke
2018PharmacoEconomics (Auckland)10 citations Open access
Semantic Scholar
Predictors of early discontinuation of basal insulin therapy in type 2 diabetes in primary care.
K. Kostev, F. Dippel, W. Rathmann
2016Primary Care Diabetes9 citations
Semantic Scholar
Different Injection Frequencies of Basal Insulins in Type 2 Diabetes Patients under Real-Life Conditions: A Retrospective Database Analysis
W. Rathmann, F. Dippel, K. Kostev
2013Journal of Diabetes Science and Technology8 citations Open access
Semantic Scholar
Micro- and macrovascular outcomes in Type 2 diabetic patients treated with insulin glulisine or human regular insulin: a retrospective database analysis.
S. Kress, K. Kostev, F. Dippel, G. Giani +1 more
2012International journal of clinical pharmacology and therapeutics8 citations
Semantic Scholar
Prevalence of high-risk cardiovascular patients with therapy-resistant hypercholesterolemia
K. Kostev, K. Parhofer, F. Dippel
2016Cardiovascular Endocrinology7 citations Open access
Semantic Scholar
Risk of hypoglycaemia in type 2 diabetes patients under different insulin regimens: a primary care database analysis
K. Kostev, F. Dippel, W. Rathmann
2015German medical science : GMS e-journal7 citations Open access
Semantic Scholar
Predictors of Insulin Initiation in Metformin and Sulfonylurea Users in Primary Care Practices
K. Kostev, F. Dippel, W. Rathmann
2014Journal of Diabetes Science and Technology7 citations Open access
Semantic Scholar
Resource Consumption and Costs of Treatment in Patients with Type 1 Diabetes under Intensified Conventional Therapy under German Real-Life Conditions
K. Kostev, F. Dippel, R. Bierwirth
2013Journal of Diabetes Science and Technology7 citations Open access
Semantic Scholar
Predictors for the initiation of a basal supported oral therapy (BOT) in type 2 diabetic patients under real-life conditions in Germany.
K. Kostev, F. Dippel
2012Primary Care Diabetes7 citations
Semantic Scholar
Cost comparison of insulin glargine with insulin detemir in a basal-bolus regime with mealtime insulin aspart in type 2 diabetes in Germany
S. Pscherer, E. Dietrich, F. Dippel, A. Neilson
2010German medical science : GMS e-journal7 citations
Semantic Scholar
Risk of diabetic foot ulceration during treatment with insulin glargine and NPH insulin.
K. Kostev, F. Dippel, T. Rockel, T. Siegmund
2012Journal of Wound Care6 citations
Semantic Scholar
Comparison of basal insulin therapies with regard to the risk of acute myocardial infarction in patients with type 2 diabetes: an observational cohort study
B. Kollhorst, S. Behr, D. Enders, F. Dippel +2 more
2015Diabetes, obesity and metabolism5 citations
Semantic Scholar
PATIENT PRIORITIES FOR TREATMENT ATTRIBUTES IN ADJUNCTIVE DRUG THERAPY OF SEVERE HYPERCHOLESTEROLEMIA IN GERMANY: AN ANALYTIC HIERARCHY PROCESS
A. Mühlbacher, A. Kaczynski, F. Dippel, S. Bethge
2018International Journal of Technology Assessment in Health Care4 citations
Semantic Scholar
Basal Supported Oral Therapy with Insulin Glargine Results in Longer Persistence and Lower Costs Compared with Insulin Detemir in Type 2 Diabetics in Germany
M. Pfohl, F. Dippel, K. Kostev, S. Fuchs +1 more
20114 citations
Semantic Scholar
[Analysis of Secondary Data to Determine the Prevalence of Cardiovascular High Risk Patients with Hypercholesterolemia and Refractory Course of Treatment].
F. Dippel, K. Parhofer, Thomas Müller-Bohn, S. Gebhardt +1 more
2017Deutsche Medizinische Wochenschrift3 citations
Semantic Scholar
‘Knowing what matters in diabetes: healthier below 7’: results of the campaign’s first 10 years (part 1): participants with known type 2 diabetes
S. Jacob, Andrea Klimke-Hübner, F. Dippel, W. Hopfenmüller
2016Cardiovascular Endocrinology3 citations Open access
Semantic Scholar
‘Knowing what Matters in diabetes: Healthier below 7’: results of the campaign’s first 10 years (part 2), participants without known diabetes history
S. Jacob, Andrea Klimke-Huebner, F. Dippel, W. Hopfenmueller
2016Cardiovascular Endocrinology2 citations Open access
Semantic Scholar
Comparison of treatment costs in inadequately controlled type 2 diabetes in Germany based on the APOLLO trial with insulin glargine
R. Bretzel, F. Dippel, T. Linn, A. Neilson
2009Journal of Medical Economics2 citations Open access
Semantic Scholar
Reduction of LDL-C Levels is Most Important - Patient Preferences for Drug Treatment Adjunct to LDL-C Apheresis in Severe Hypercholesterolemia
A. Mühlbacher, A. Sadler, F. Dippel, C. Juhnke
20170 citations Open access
Semantic Scholar
Heterogeneous Preferences in the Adjunct Drug Treatment of Severe Hypercholesterolemia: A Latent-Class Analysis
A. Mühlbacher, A. Sadler, F. Dippel, C. Juhnke
20170 citations
Semantic Scholar
Prevalence of Therapy-Resistant Hypercholesterolemia in High-Risk Cardiovascular Patients in Germany
K. Kostev, K. Parhofer, S. Dombrowski, F. Dippel
20160 citations Open access
Semantic Scholar
Die Inzidenz von Frakturen bei Patienten mit und ohne Typ-2-Diabetes unter realen Versorgungsbedingungen in Deutschland
S. Pscherer, K. Kostev, F. Dippel, W. Rathmann
20150 citations
Semantic Scholar
Glycemic control after initiating basal insulin therapy in patients with type 2 diabetes: a primary care database analysis
K. Kostev, F. Dippel, W. Rathmann
20150 citations
Semantic Scholar
Inzidenz von Frakturen bei Typ-2-Diabetespatienten unter antihyperglykämischer Therapie im Versorgungsalltag: Retrospektive Datenbankanalyse
S. Pscherer, K. Kostev, F. Dippel, W. Rathmann
20150 citations
Semantic Scholar
Unterschiedliche Injektionsfrequenzen von Basalinsulinen bei Patienten mit Typ 2 Diabetes unter realen Versorgungsbedingungen - eine retrospektive Datenbankanalyse
K. Kostev, F. Dippel, W. Rathmann
20130 citations
Semantic Scholar
PDB5 Micro- and Macrovascular Outcomes in Primary Care Patients with Type 2 Diabetes Treated with Insulin Glulisine or Human Regular Insulin: A Retrospective German Database Analysis
S. Kress, F. Dippel, K. Kostev, G. Giani +1 more
20110 citations Open access
Semantic Scholar
Changes in health policy in discussion
M. Middeke, A. Fritsche, O. Schöffski, F. Dippel +2 more
20080 citations
Semantic Scholar
[LAPTOP trial--results of an health economics evaluation].
F. Dippel
2008Deutsche Medizinische Wochenschrift0 citations
Semantic Scholar

Frequent co-authors

Invite them to SciRah by sharing their profile.

K. Kostev×23
Invite
K. Kostev — researcher profile on SciRah
W. Rathmann×8
Invite
W. Rathmann — researcher profile on SciRah
A. Mühlbacher×4
Invite
A. Mühlbacher — researcher profile on SciRah
S. Pscherer×3
Invite
S. Pscherer — researcher profile on SciRah

×3

Invite

W. Rathmann — researcher profile on SciRah

Invite

M. Pfohl — researcher profile on SciRah

Invite

A. Sadler — researcher profile on SciRah

Invite

C. Juhnke — researcher profile on SciRah

Invite

K. Parhofer — researcher profile on SciRah

Invite

W. Rathmann — researcher profile on SciRah

Invite

T. Kohlmann — researcher profile on SciRah

Invite

K. Theobald — researcher profile on SciRah